Terms: = Prostate cancer AND PWWP2A, Q8IYR3_HUMAN, Q96N64, MST101, MGC132770, KIAA1935, ENSG00000170234, 114825 AND Treatment
8015 results:
1. JUN mediates the senescence associated secretory phenotype and immune cell recruitment to prevent prostate cancer progression.
Redmer T; Raigel M; Sternberg C; Ziegler R; Probst C; Lindner D; Aufinger A; Limberger T; Trachtova K; Kodajova P; Högler S; Schlederer M; Stoiber S; Oberhuber M; Bolis M; Neubauer HA; Miranda S; Tomberger M; Harbusch NS; Garces de Los Fayos Alonso I; Sternberg F; Moriggl R; Theurillat JP; Tichy B; Bystry V; Persson JL; Mathas S; Aberger F; Strobl B; Pospisilova S; Merkel O; Egger G; Lagger S; Kenner L
Mol Cancer; 2024 May; 23(1):114. PubMed ID: 38811984
[TBL] [Abstract] [Full Text] [Related]
2. Cytosine Deaminase-Overexpressing hTERT-Immortalized Human Adipose Stem Cells Enhance the Inhibitory Effects of Fluorocytosine on Tumor Growth in Castration Resistant prostate cancer.
Kim JH; Yang HJ; Lee SH; Song YS
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791557
[TBL] [Abstract] [Full Text] [Related]
3. Discordant Health Implications and Molecular Mechanisms of Vitamin D in Clinical and Preclinical Studies of prostate cancer: A Critical Appraisal of the Literature Data.
Fendler A; Stephan C; Ralla B; Jung K
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791324
[TBL] [Abstract] [Full Text] [Related]
4. Human-like intelligent automatic treatment planning of head and neck cancer radiation therapy.
Gao Y; Kyun Park Y; Jia X
Phys Med Biol; 2024 May; 69(11):. PubMed ID: 38744304
[No Abstract] [Full Text] [Related]
5. Increasing the radiation-induced cytotoxicity by silver nanoparticles and docetaxel in prostate cancer cells.
Hatami Zharabad S; Mohammadian M; Zohdi Aghdam R; Hassanzadeh Dizaj M; Behrouzkia Z
Mol Biol Rep; 2024 May; 51(1):633. PubMed ID: 38724835
[TBL] [Abstract] [Full Text] [Related]
6. CRISPR-Cas9 genome and long non-coding RNAs as a novel diagnostic index for prostate cancer therapy via liposomal-coated compounds.
Kadry MO; Abdel-Megeed RM
PLoS One; 2024; 19(5):e0302264. PubMed ID: 38723038
[TBL] [Abstract] [Full Text] [Related]
7. Pan-cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target Across Human Malignancies.
Miller CD; Lozada JR; Zorko NA; Elliott A; Makovec A; Radovich M; Heath EI; Agarwal N; Mckay RR; Garje R; Bastos BR; Hoon DSB; Orme JJ; Sartor O; VanderWalde A; Nabhan C; Sledge G; Shenderov E; Dehm SM; Lou E; Miller JS; Hwang JH; Antonarakis ES
Cancer Res Commun; 2024 May; 4(5):1369-1379. PubMed ID: 38709075
[TBL] [Abstract] [Full Text] [Related]
8. Delivery of Chlorambucil to the Brain Using Surface Modified Solid Lipid Nanoparticles.
Patra S; Dey J; Kar S; Chakraborty A
ACS Appl Bio Mater; 2024 May; 7(5):3403-3413. PubMed ID: 38700026
[TBL] [Abstract] [Full Text] [Related]
9. Dual-mode fluorescence and colorimetric smartphone-based sensing platform with oxidation-induced self-assembled nanoflowers for sarcosine detection.
Liu P; Sun Q; Gai Z; Yang F; Yang Y
Anal Chim Acta; 2024 Jun; 1306():342586. PubMed ID: 38692787
[TBL] [Abstract] [Full Text] [Related]
10. Spatial distribution of tumor-associated macrophages in an orthotopic prostate cancer mouse model.
Grayson KA; Greenlee JD; Himmel LE; Hapach LA; Reinhart-King CA; King MR
Pathol Oncol Res; 2024; 30():1611586. PubMed ID: 38689823
[TBL] [Abstract] [Full Text] [Related]
11. Antiproliferative and Apoptotic Effects of Murici (Byrsonima crassifolia (L.) Kunth and verbascifolia (L.) DC) and Taperebá (Spondias mombin L.) Extracts in Human prostate Cell Line (PC-3).
Amaral Muxfeldt Paim TOD; Simas NF; Abreu JP; Rosa L; Passos Barbosa Lima T; Teodoro AJ
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1339-1347. PubMed ID: 38679995
[TBL] [Abstract] [Full Text] [Related]
12. Patient-Derived Xenograft Models for Translational prostate cancer Research and Drug Development.
Philp LK
Methods Mol Biol; 2024; 2806():153-185. PubMed ID: 38676802
[TBL] [Abstract] [Full Text] [Related]
13. Myeloid-derived suppressor cells attenuate the antitumor efficacy of radiopharmaceutical therapy using
Muralidhar A; Hernandez R; Morris ZS; Comas Rojas H; Bio Idrissou M; Weichert JP; McNeel DG
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38663936
[TBL] [Abstract] [Full Text] [Related]
14. Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study.
Bergamini M; Dalla Volta A; Palumbo C; Zamboni S; Triggiani L; Zamparini M; Laganà M; Rinaudo L; Di Meo N; Caramella I; Bresciani R; Valcamonico F; Borghetti P; Guerini A; Farina D; Antonelli A; Simeone C; Mazziotti G; Berruti A
Elife; 2024 Apr; 13():. PubMed ID: 38656229
[TBL] [Abstract] [Full Text] [Related]
15. Developing a Novel Enzalutamide-Resistant prostate cancer Model via AR F877L Mutation in LNCaP Cells.
Wang R; Ma S; Xu N; Gan Y; Li P; Zhang J; Zhang Z; Gu Q; Xiang J
Curr Protoc; 2024 Apr; 4(4):e1033. PubMed ID: 38652202
[TBL] [Abstract] [Full Text] [Related]
16. Skin Changes in Suspected Lyme Disease.
Vržogić P; Perica A
Acta Dermatovenerol Croat; 2023 Dec; 31(4):225-228. PubMed ID: 38651851
[TBL] [Abstract] [Full Text] [Related]
17. Exploring the role of combined external beam radiotherapy and targeted radioligand therapy with [
Arbuznikova D; Klotsotyra A; Uhlmann L; Domogalla LC; Steinacker N; Mix M; Niedermann G; Spohn SKB; Freitag MT; Grosu AL; Meyer PT; Gratzke C; Eder M; Zamboglou C; Eder AC
Theranostics; 2024; 14(6):2560-2572. PubMed ID: 38646643
[TBL] [Abstract] [Full Text] [Related]
18. DB-1310, an ADC comprised of a novel anti-HER3 antibody conjugated to a DNA topoisomerase I inhibitor, is highly effective for the treatment of HER3-positive solid tumors.
Li X; Yao J; Qu C; Luo L; Li B; Zhang Y; Zhu Z; Qiu Y; Hua H
J Transl Med; 2024 Apr; 22(1):362. PubMed ID: 38632563
[TBL] [Abstract] [Full Text] [Related]
19. ELK3 destabilization by speckle-type POZ protein suppresses prostate cancer progression and docetaxel resistance.
Lee CJ; Lee H; Kim SR; Nam SB; Lee GE; Yang KE; Lee GJ; Chun SH; Kang HC; Lee JY; Lee HS; Cho SJ; Cho YY
Cell Death Dis; 2024 Apr; 15(4):274. PubMed ID: 38632244
[TBL] [Abstract] [Full Text] [Related]
20. Understanding and overcoming resistance to immunotherapy in genitourinary cancers.
Evans ST; Jani Y; Jansen CS; Yildirim A; Kalemoglu E; Bilen MA
Cancer Biol Ther; 2024 Dec; 25(1):2342599. PubMed ID: 38629578
[TBL] [Abstract] [Full Text] [Related]
[Next]
